Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Wolyncewicz
R-Ivac Salvage Therapy in Relapsed and Refractory DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Very Early FDG Pet/Ct Scan May Predict Outcomes in Relapsed or Refractory DLBCL Patients Treated With Salvage Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Poor Outcomes of Patients With Relapsed/Refractory DLBCL Requiring More Than One Salvage Therapy Followed by Autologous HCT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Real-World Bendamustine Use in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pet-Adapted Nivolumab +/- Ice as Initial Salvage Therapy in Relapsed/Refractory Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Systematic Review of the Clinical Efficacy of Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Global Pivotal Phase 2 Trial of the Cd19-Targeted Therapy Ctl019 in Adult Patients With Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (Dlbcl)-An Interim Analysis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Toxicity-Reduced, Myeloablative Allograft Followed by Lenalidomide Maintenance as Salvage Therapy for Refractory/Relapsed Myeloma Patients
Bone Marrow Transplantation
Transplantation
Hematology
Bet Inhibitor Rg6146, Venetoclax, and Rituximab Is a Highly Active Regimen in Relapsed/Refractory (R/R) Dlbcl: Initial Report of Phase 1b Safety, Biomarker, and Response Data
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
Clinical Hematology International
